BDBM468292 3-(9-anthracene carboxamide)-3,3′-Dideoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1′-sulfanediyl-di-β-D-galactopyranoside::US10800804, Example S20a

SMILES CC(C)(C)c1c2ccccc2c(C(=O)NC2C(O)[C@@H](CO)OC(S[C@@H]3OC(CO)[C@H](O)[C@@H](C3O)n3cc(nn3)-c3cccc(F)c3)[C@@H]2O)c2ccccc12

InChI Key InChIKey=SOTBIJCFBZDKAF-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 468292   

TargetGalectin-3(Human)
TBA

US Patent
LigandPNGBDBM468292(US10800804, Example S20a | 3-(9-anthracene carboxa...)
Affinity DataKd:  64nMAssay Description:The affinity of compounds S8a-c, S11, S16, S20a-b and S21 for galectins were determined by a fluorescence anisotropy assay where the compound was use...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetGalectin-1(Human)
TBA

US Patent
LigandPNGBDBM468292(US10800804, Example S20a | 3-(9-anthracene carboxa...)
Affinity DataKd:  380nMAssay Description:The affinity of compounds S8a-c, S11, S16, S20a-b and S21 for galectins were determined by a fluorescence anisotropy assay where the compound was use...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent